{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/migraine/","result":{"data":{"firstChapter":{"id":"f5de766d-b899-5cb2-978f-7194e0cbeaf4","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field 737eb8b7-3ee0-4e15-8901-4e754d355b05 --><h1>Migraine: Summary</h1><!-- end field 737eb8b7-3ee0-4e15-8901-4e754d355b05 -->","htmlStringContent":"<!-- begin item 83b87f43-d6ad-4c05-8db6-5749a6c11eff --><!-- begin field bb0c6c48-b8ec-4290-a10a-f80d3659de82 --><ul><li>Migraine is a common primary headache disorder. It is characterized by attacks of moderate or severe headache and associated symptoms such as photophobia, phonophobia, nausea and vomiting.<ul><li>Headache is typically unilateral, pulsating or throbbing and lasts 4–72 hours.</li><li>Migraine symptoms are often aggravated by, or cause avoidance of, routine activities of daily life (such as walking).</li></ul></li><li>Migraine can occur with or without aura.<ul><li>Aura is characterized by transient focal neurological symptoms (for example visual symptoms such as zigzag lines and/or scotoma or sensory symptoms such as pins and needles) which usually precede, or in some people, accompany the headache. </li></ul></li><li>Depending on the frequency of attacks migraine can be classified as episodic or chronic.</li><li>Migraine is thought to affect about 1 in 7 people globally — it is two to three times more common in women than men.</li><li>Prognosis generally improves with increasing age. In pregnancy most women will notice an improvement in frequency and severity of attacks.</li><li>A thorough clinical assessment is essential in the diagnosis of migraine, as other causes of headache (which can be serious and life-threatening) can present with similar symptoms and signs.<ul><li>A headache diary may be useful to identify potential triggers (such as stress, specific foods, dehydration, missed meals or disturbed sleep) and monitor effectiveness of treatment.</li></ul></li><li>Depending on the specific clinical situation, management of acute migraine includes:<ul><li>Trigger avoidance (where possible) and lifestyle changes.</li><li>Drug treatment with simple analgesia (such as paracetamol, ibuprofen or aspirin), or a triptan or combination therapy with a triptan and paracetamol or a nonsteroidal anti-inflammatory drug.</li><li>An anti-emetic (prochlorperazine or metoclopramide) may be added even in the absence of nausea or vomiting.</li></ul></li><li>Preventative treatment (such as propranolol or topiramate) may be considered in adults who are not pregnant or breastfeeding if:<ul><li>Attacks are frequent or prolonged and severe despite appropriate acute treatment.</li><li>The person is at risk of medication overuse headache.</li></ul></li><li>Preventative treatment should not be initiated in primary care for pregnant or breastfeeding women or children.<ul><li>Many preventative drugs have limited evidence of safety or are contraindicated in these groups — specialist advice is required.</li></ul></li><li>Admission or referral is indicated if:<ul><li>A serious cause of headache is suspected.</li><li>The person is in severe, uncontrolled status migrainosus (migraine lasting for more than 72 hours).</li><li>A complication of migraine has developed.</li><li>Atypical symptoms are present.</li><li>The diagnosis is uncertain.</li><li>Optimal treatment in primary care has failed.</li><li>Preventative treatment is being considered in children or pregnant or breastfeeding women.</li></ul></li></ul><!-- end field bb0c6c48-b8ec-4290-a10a-f80d3659de82 --><!-- end item 83b87f43-d6ad-4c05-8db6-5749a6c11eff -->","topic":{"id":"b2a19577-fc3a-5b75-948b-7c86424dba8f","topicId":"8d5c9fe8-c317-4160-9aa5-50f3a0456472","topicName":"Migraine","slug":"migraine","aliases":[],"chapters":[{"id":"f5de766d-b899-5cb2-978f-7194e0cbeaf4","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"57045461-bc73-53e8-9968-49ab778a037a","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"32406f3a-91ba-5801-9ef0-87ad7d9b3133","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"52e6d993-e2b2-59c3-920f-27f34a7ec2eb","slug":"changes","fullItemName":"Changes"},{"id":"9560b149-423e-5bf5-8239-ae3f4bc97616","slug":"update","fullItemName":"Update"}]},{"id":"f6c897d2-fd52-5c54-a91b-1b366dced50e","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"058608e6-7b11-54ed-9d12-69b94ea020cf","slug":"goals","fullItemName":"Goals"},{"id":"95d8aa4b-0bce-5da9-b56a-a612d637a001","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"f9b5443b-1c38-5f3c-be42-3e7fffa429e3","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"d5644cb5-763c-596c-8c47-919fec89ce47","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"92308844-16f7-5eeb-9c0a-ad97a07896ec","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"b97a29bb-bac7-5bc8-907c-210d887086f2","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"986db6f6-7568-5e6e-8095-5ce116d22307","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"b6d1719e-8f6a-509b-90d2-7d1f38e19b05","slug":"definition","fullItemName":"Definition"},{"id":"e35d9975-5859-5454-9539-fab1a8ca6a43","slug":"causes","fullItemName":"Causes"},{"id":"3d8350c0-8bc5-5793-a577-411bc703d36f","slug":"prevalence","fullItemName":"Prevalence"},{"id":"eea7fb2e-ce45-5fa7-9ff5-5399f8305dd7","slug":"prognosis","fullItemName":"Prognosis"},{"id":"ad3ec7a1-a418-5232-b554-b202784e3f46","slug":"complications","fullItemName":"Complications"}]},{"id":"23b2a2ec-5694-51eb-97af-5e80f8d0b792","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"86e96919-af81-53dc-805a-36533fa27637","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"1b00b35a-f7c5-5dc3-bd7d-6e72a973af14","slug":"assessment","fullItemName":"Assessment"},{"id":"33c2a435-70da-50e9-b336-2d81b68f99c9","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"1ece6bbf-1986-5392-be1d-427e9603f26a","slug":"management","fullItemName":"Management","subChapters":[{"id":"eb14162e-c87a-5ca7-8eda-4acb5c336298","slug":"adults","fullItemName":"Scenario: Adults"},{"id":"3bced75d-3a79-536f-976d-875a40bf1a8d","slug":"young-people-aged-12-17-years","fullItemName":"Scenario: Young people aged 12-17 years"},{"id":"604f5c24-3920-5626-893b-9c27575decc6","slug":"pregnant-or-breastfeeding-women","fullItemName":"Scenario: Pregnant or breastfeeding women"}]},{"id":"8e2844f3-6843-5776-a5a1-59b0cabc5b93","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"d1661673-77b9-587b-94ce-e5b6ff9de8c5","slug":"drugs-for-acute-migraine","fullItemName":"Drugs for acute migraine"},{"id":"b69cd3a2-8118-552d-ba35-c7db1a498617","slug":"drugs-for-the-prevention-of-migraine","fullItemName":"Drugs for the prevention of migraine"}]},{"id":"daf55050-4154-5b6d-b8ab-0f86775d1038","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"0fbeb3e2-26df-5d63-a045-8af31aed07ef","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"88a22f7c-7eb4-5b57-a406-ab204723d6c0","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"596ed3f2-0ac4-5fd9-9046-b304311543ee","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"c4597510-7ec3-5f98-b5a5-3ef55cd51b5e","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"79a12dcb-038c-5fd4-a311-648c3ee61102","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"41030681-d726-58c4-b509-29748e404597","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"9a8a7e48-db76-50eb-a585-96fe1b4a5977","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"b2a19577-fc3a-5b75-948b-7c86424dba8f","topicId":"8d5c9fe8-c317-4160-9aa5-50f3a0456472","topicName":"Migraine","slug":"migraine","aliases":[],"topicSummary":"Migraine is a primary episodic headache disorder. It is characterized by severe headaches with symptoms such as photophobia, nausea and vomiting","lastRevised":"Last revised in October 2020","nextPlannedReviewBy":"2024-04-01T00:00:00+01:00","nextPlannedReviewByDateTime":"2024-03","nextPlannedReviewByDisplay":"March 2024","specialities":[{"id":"08590215-7450-5fd4-bb09-b98865ce23ee","name":"Neurological","slug":"neurological"}],"chapters":[{"id":"f5de766d-b899-5cb2-978f-7194e0cbeaf4","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"57045461-bc73-53e8-9968-49ab778a037a","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"32406f3a-91ba-5801-9ef0-87ad7d9b3133","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"52e6d993-e2b2-59c3-920f-27f34a7ec2eb","slug":"changes","fullItemName":"Changes"},{"id":"9560b149-423e-5bf5-8239-ae3f4bc97616","slug":"update","fullItemName":"Update"}]},{"id":"f6c897d2-fd52-5c54-a91b-1b366dced50e","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"058608e6-7b11-54ed-9d12-69b94ea020cf","slug":"goals","fullItemName":"Goals"},{"id":"95d8aa4b-0bce-5da9-b56a-a612d637a001","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"f9b5443b-1c38-5f3c-be42-3e7fffa429e3","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"d5644cb5-763c-596c-8c47-919fec89ce47","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"92308844-16f7-5eeb-9c0a-ad97a07896ec","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"b97a29bb-bac7-5bc8-907c-210d887086f2","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"986db6f6-7568-5e6e-8095-5ce116d22307","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"b6d1719e-8f6a-509b-90d2-7d1f38e19b05","slug":"definition","fullItemName":"Definition"},{"id":"e35d9975-5859-5454-9539-fab1a8ca6a43","slug":"causes","fullItemName":"Causes"},{"id":"3d8350c0-8bc5-5793-a577-411bc703d36f","slug":"prevalence","fullItemName":"Prevalence"},{"id":"eea7fb2e-ce45-5fa7-9ff5-5399f8305dd7","slug":"prognosis","fullItemName":"Prognosis"},{"id":"ad3ec7a1-a418-5232-b554-b202784e3f46","slug":"complications","fullItemName":"Complications"}]},{"id":"23b2a2ec-5694-51eb-97af-5e80f8d0b792","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"86e96919-af81-53dc-805a-36533fa27637","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"1b00b35a-f7c5-5dc3-bd7d-6e72a973af14","slug":"assessment","fullItemName":"Assessment"},{"id":"33c2a435-70da-50e9-b336-2d81b68f99c9","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"1ece6bbf-1986-5392-be1d-427e9603f26a","slug":"management","fullItemName":"Management","subChapters":[{"id":"eb14162e-c87a-5ca7-8eda-4acb5c336298","slug":"adults","fullItemName":"Scenario: Adults"},{"id":"3bced75d-3a79-536f-976d-875a40bf1a8d","slug":"young-people-aged-12-17-years","fullItemName":"Scenario: Young people aged 12-17 years"},{"id":"604f5c24-3920-5626-893b-9c27575decc6","slug":"pregnant-or-breastfeeding-women","fullItemName":"Scenario: Pregnant or breastfeeding women"}]},{"id":"8e2844f3-6843-5776-a5a1-59b0cabc5b93","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"d1661673-77b9-587b-94ce-e5b6ff9de8c5","slug":"drugs-for-acute-migraine","fullItemName":"Drugs for acute migraine"},{"id":"b69cd3a2-8118-552d-ba35-c7db1a498617","slug":"drugs-for-the-prevention-of-migraine","fullItemName":"Drugs for the prevention of migraine"}]},{"id":"daf55050-4154-5b6d-b8ab-0f86775d1038","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"0fbeb3e2-26df-5d63-a045-8af31aed07ef","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"88a22f7c-7eb4-5b57-a406-ab204723d6c0","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"596ed3f2-0ac4-5fd9-9046-b304311543ee","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"c4597510-7ec3-5f98-b5a5-3ef55cd51b5e","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"79a12dcb-038c-5fd4-a311-648c3ee61102","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"41030681-d726-58c4-b509-29748e404597","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"9a8a7e48-db76-50eb-a585-96fe1b4a5977","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"b2a19577-fc3a-5b75-948b-7c86424dba8f"}},"staticQueryHashes":["3666801979"]}